Hickman-Brenner F W, Vohra M P, Huntley-Carter G P, Fanning G R, Lowery V A, Brenner D J, Farmer J J
J Clin Microbiol. 1985 Feb;21(2):234-9. doi: 10.1128/jcm.21.2.234-239.1985.
Leminorella is proposed as a new genus for the group of Enterobacteriaceae formerly known as Enteric Group 57. Strains of Leminorella gave positive tests for H2S production, acid production from L-arabinose and D-xylose, and tyrosine clearing; they were negative for indole production, Voges-Proskauer, urea hydrolysis, phenylalanine deaminase, motility, gelatin liquefaction, lysine and ornithine decarboxylases, arginine dihydrolase, growth in KCN, and acid production from adonitol, D-arabitol, cellobiose, erythritol, D-galactose, myo-inositol, lactose, maltose, D-mannitol, D-mannose, melibiose, alpha-CH3-glucoside, raffinose, L-rhamnose, salicin, D-sorbitol, sucrose, and trehalose. By DNA hybridization, strains of Leminorella were only 3 to 16% related to other Enterobacteriaceae and were divided into three groups. Leminorella grimontii is proposed as the type species for the genus and strain CDC 1944-81, ATCC 33999, is designated as the type strain. There were four strains of L. grimontii from stool specimens and two from urine specimens. L. richardii is proposed as the name for the second species (type strain, CDC 0978-82, ATCC 33998). All four L. richardii strains were from stool specimens. L. grimontii can be distinguished from L. richardii because it produces gas from glucose (100%) and acid from dulcitol (83%) and is methyl red positive (100%). One strain, CDC 3346-72, was more related to L. grimontii by DNA hybridization than to L. richardii, but the lower relatedness to both of these species indicated that it may be a third species. Biochemically it could not be distinguished from L. grimontii. All Leminorella strains were resistant (no zone of inhibition) to ampicillin, carbenicillin, and cephalothin. Some of the Leminorella strains were sent to us for Salmonella serotyping, and two reacted weakly in Salmonella antisera. The clinical significance of Leminorella is unknown.
勒米诺菌属被提议作为以前称为肠道菌群57的肠杆菌科菌群的一个新属。勒米诺菌属菌株硫化氢产生试验、L-阿拉伯糖和D-木糖产酸试验以及酪氨酸水解试验呈阳性;吲哚产生试验、Voges-Proskauer试验、尿素水解试验、苯丙氨酸脱氨酶试验、动力试验、明胶液化试验、赖氨酸和鸟氨酸脱羧酶试验、精氨酸双水解酶试验、在氰化钾中生长试验以及adonitol、D-阿拉伯糖醇、纤维二糖、赤藓醇、D-半乳糖、肌醇、乳糖、麦芽糖、D-甘露醇、D-甘露糖、蜜二糖、α-CH3-葡萄糖苷、棉子糖、L-鼠李糖、水杨苷、D-山梨醇、蔗糖和海藻糖产酸试验呈阴性。通过DNA杂交,勒米诺菌属菌株与其他肠杆菌科的相关性仅为3%至16%,并分为三组。勒米诺菌属格氏菌被提议作为该属的模式种,菌株CDC 1944 - 81、ATCC 33999被指定为模式菌株。有四株来自粪便标本的格氏勒米诺菌和两株来自尿液标本的格氏勒米诺菌。勒米诺菌属理查氏菌被提议作为第二个种的名称(模式菌株,CDC 0978 - 82、ATCC 33998)。所有四株理查氏勒米诺菌均来自粪便标本。格氏勒米诺菌可与理查氏勒米诺菌区分开来,因为它能从葡萄糖产气(100%),从卫矛醇产酸(83%),且甲基红试验呈阳性(100%)。一株菌株CDC 3346 - 72通过DNA杂交与格氏勒米诺菌的相关性高于与理查氏勒米诺菌的相关性,但与这两个种的较低相关性表明它可能是第三个种。在生化特性上它无法与格氏勒米诺菌区分。所有勒米诺菌属菌株对氨苄西林、羧苄西林和头孢噻吩耐药(无抑菌圈)。一些勒米诺菌属菌株被送来进行沙门菌血清分型,其中两株在沙门菌抗血清中反应较弱。勒米诺菌属的临床意义尚不清楚。